Brady Ryan P, Urbina Elaine M, Gao Zhiqian, Dabelea Dana, Lustigova Eva, Marcovina Santica, Mottl Amy K, Pihoker Catherine, Reynolds Kristi, Sancrainte LeAnne, Dolan Lawrence M, Shah Amy S
Division of Endocrinology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, OH.
Heart Institute, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, OH.
Diabetes Care. 2025 Apr 1;48(4):639-647. doi: 10.2337/dc24-2320.
To assess the relationship between arterial stiffness, an early marker of macrovascular cardiovascular disease, and microvascular complications in adolescents and young adults with youth-onset diabetes.
This study included 1,226 individuals (median age at initial visit 18 years; 58% female; 53% non-Hispanic White, 22% non-Hispanic Black, and 20% Hispanic) with youth-onset type 1 or type 2 diabetes from the SEARCH for Diabetes in Youth Study. Arterial stiffness measures included pulse wave velocity for carotid femoral, carotid radial, femoral foot, and augmentation index (AIx). Microvascular complications included microalbuminuria, peripheral neuropathy, and retinopathy. Participants were followed up once at ∼5 years.
Cross-sectionally, in type 1 diabetes, AIx was associated with higher odds of having any one microvascular complication (odds ratio [OR] 1.35; 95% CI 1.04-1.76), microalbuminuria (OR 2.76; 95% CI 1.78-4.39), neuropathy (OR 1.63; 95% CI 1.07-2.50), and retinopathy (OR 1.37; 95% CI 1.06-1.79). In type 2 diabetes, AIx was associated with higher odds of microalbuminuria (OR 2.05; 95% CI 1.04-4.33; all P < 0.05). In longitudinal analysis, in type 1 diabetes, a change in AIx was associated with the development of any one microvascular complication (OR 1.45; 95% CI 1.15-1.82), microalbuminuria (OR 5.42; 95% CI 1.98-14.80), neuropathy (OR 2.03; 95% CI 1.22-3.40), and retinopathy (OR 1.48; 95% CI 1.15-1.90). In type 2 diabetes, a change in AIx was associated with the development of microalbuminuria (OR 21.98; 95% CI 1.30-372.88; all P < 0.05).
Arterial stiffness is related to and predicts microvascular complications in youth-onset type 1 and type 2 diabetes.
评估大血管心血管疾病的早期标志物动脉僵硬度与青年发病型糖尿病青少年及青年微血管并发症之间的关系。
本研究纳入了来自青少年糖尿病研究(SEARCH for Diabetes in Youth Study)的1226例青年发病型1型或2型糖尿病患者(首次就诊时的中位年龄为18岁;58%为女性;53%为非西班牙裔白人,22%为非西班牙裔黑人,20%为西班牙裔)。动脉僵硬度测量指标包括颈股脉搏波速度、颈桡脉搏波速度、股踝脉搏波速度和增强指数(AIx)。微血管并发症包括微量白蛋白尿、周围神经病变和视网膜病变。参与者在约5年后进行了一次随访。
横断面分析中,在1型糖尿病患者中,AIx与发生任何一种微血管并发症的较高几率相关(比值比[OR]1.35;95%置信区间[CI]1.04 - 1.76),与微量白蛋白尿(OR 2.76;95% CI 1.78 - 4.39)、神经病变(OR 1.63;95% CI 1.07 - 2.50)和视网膜病变(OR 1.37;95% CI 1.06 - 1.79)相关。在2型糖尿病患者中,AIx与微量白蛋白尿的较高几率相关(OR 2.05;95% CI 1.04 - 4.33;所有P < 0.05)。纵向分析中,在1型糖尿病患者中,AIx的变化与发生任何一种微血管并发症(OR 1.45;95% CI 1.15 - 1.